Stock analysts at HC Wainwright dropped their FY2024 earnings per share estimates for SpringWorks Therapeutics in a research note issued on Wednesday, February 12th. HC Wainwright analyst R. Burns now ...
Discover the latest strategic moves of Duquesne Family Office's $3.72B portfolio, including new stakes, increased investments ...
Analysts at HC Wainwright issued their Q2 2025 earnings estimates for Arrowhead Pharmaceuticals in a research report issued ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results